179 related articles for article (PubMed ID: 37762260)
1. mAb-Functionalized Biomimetic MamC-Mediated-Magnetoliposomes as Drug Delivery Systems for Cancer Therapy.
Oltolina F; Santaella Escolano MDC; Jabalera Y; Prat M; Jimenez Lopez C
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762260
[TBL] [Abstract][Full Text] [Related]
2. pH-Dependent Adsorption Release of Doxorubicin on MamC-Biomimetic Magnetite Nanoparticles.
García Rubia G; Peigneux A; Jabalera Y; Puerma J; Oltolina F; Elert K; Colangelo D; Gómez Morales J; Prat M; Jimenez-Lopez C
Langmuir; 2018 Nov; 34(45):13713-13724. PubMed ID: 30394747
[TBL] [Abstract][Full Text] [Related]
3. Magnetoliposomes of mixed biomimetic and inorganic magnetic nanoparticles as enhanced hyperthermia agents.
Jabalera Y; Fernández-Vivas A; Iglesias GR; Delgado ÁV; Jimenez-Lopez C
Colloids Surf B Biointerfaces; 2019 Nov; 183():110435. PubMed ID: 31430636
[TBL] [Abstract][Full Text] [Related]
4. Biomimetic Magnetite Nanoparticles as Targeted Drug Nanocarriers and Mediators of Hyperthermia in an Experimental Cancer Model.
Oltolina F; Peigneux A; Colangelo D; Clemente N; D'Urso A; Valente G; Iglesias GR; Jiménez-Lopez C; Prat M
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32916816
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Cytotoxic Effect of TAT-PLGA-Embedded DOXO Carried by Biomimetic Magnetic Nanoparticles upon Combination with Magnetic Hyperthermia and Photothermia.
Jabalera Y; Sola-Leyva A; Gaglio SC; Carrasco-Jiménez MP; Iglesias GR; Perduca M; Jimenez-Lopez C
Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452129
[TBL] [Abstract][Full Text] [Related]
6. Protein corona formation and its influence on biomimetic magnetite nanoparticles.
Peigneux A; Glitscher EA; Charbaji R; Weise C; Wedepohl S; Calderón M; Jimenez-Lopez C; Hedtrich S
J Mater Chem B; 2020 Jun; 8(22):4870-4882. PubMed ID: 32108191
[TBL] [Abstract][Full Text] [Related]
7. Improving the Cellular Uptake of Biomimetic Magnetic Nanoparticles.
Vurro F; Jabalera Y; Mannucci S; Glorani G; Sola-Leyva A; Gerosa M; Romeo A; Romanelli MG; Malatesta M; Calderan L; Iglesias GR; Carrasco-Jiménez MP; Jimenez-Lopez C; Perduca M
Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33803544
[No Abstract] [Full Text] [Related]
8. Biomimetic Magnetoliposomes as Oxaliplatin Nanocarriers: In Vitro Study for Potential Application in Colon Cancer.
Garcia-Pinel B; Jabalera Y; Ortiz R; Cabeza L; Jimenez-Lopez C; Melguizo C; Prados J
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32599905
[TBL] [Abstract][Full Text] [Related]
9. LGR5 as a Therapeutic Target of Antibody-Functionalized Biomimetic Magnetoliposomes for Colon Cancer Therapy.
Cepero A; Jiménez-Carretero M; Jabalera Y; Gago L; Luque C; Cabeza L; Melguizo C; Jimenez-Lopez C; Prados J
Int J Nanomedicine; 2024; 19():1843-1865. PubMed ID: 38414530
[TBL] [Abstract][Full Text] [Related]
10. Cell surface receptor targeted biomimetic apatite nanocrystals for cancer therapy.
Iafisco M; Delgado-Lopez JM; Varoni EM; Tampieri A; Rimondini L; Gomez-Morales J; Prat M
Small; 2013 Nov; 9(22):3834-44. PubMed ID: 23606568
[TBL] [Abstract][Full Text] [Related]
11. The importance of cell uptake in photothermal treatments mediated by biomimetic magnetic nanoparticles.
Lázaro M; Lupiáñez P; Sola-Leyva A; Pozo-Gualda T; Oltolina F; Jimenez-Carretero M; Jimenez-Lopez C; Carrasco-Jiménez MP; Iglesias GR
Colloids Surf B Biointerfaces; 2024 Feb; 234():113722. PubMed ID: 38160473
[TBL] [Abstract][Full Text] [Related]
12. Nanoformulation Design Including MamC-Mediated Biomimetic Nanoparticles Allows the Simultaneous Application of Targeted Drug Delivery and Magnetic Hyperthermia.
Jabalera Y; Oltolina F; Peigneux A; Sola-Leyva A; Carrasco-Jiménez MP; Prat M; Jimenez-Lopez C; Iglesias GR
Polymers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824256
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Photothermal-Chemotherapy Based on the Use of Biomimetic Magnetic Nanoparticles.
Jabalera Y; Sola-Leyva A; Carrasco-Jiménez MP; Iglesias GR; Jimenez-Lopez C
Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33924828
[TBL] [Abstract][Full Text] [Related]
14. Tumor Targeting by Monoclonal Antibody Functionalized Magnetic Nanoparticles.
Oltolina F; Colangelo D; Miletto I; Clemente N; Miola M; Verné E; Prat M; Follenzi A
Nanomaterials (Basel); 2019 Nov; 9(11):. PubMed ID: 31698869
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin-Biomimetic Magnetic Nanoparticle Assemblies for Colon Cancer-Targeted Chemotherapy: An In Vitro Study.
Jabalera Y; Garcia-Pinel B; Ortiz R; Iglesias G; Cabeza L; Prados J; Jimenez-Lopez C; Melguizo C
Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31390773
[TBL] [Abstract][Full Text] [Related]
16. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells.
Tarvirdipour S; Vasheghani-Farahani E; Soleimani M; Bardania H
Int J Pharm; 2016 Mar; 501(1-2):331-41. PubMed ID: 26875475
[TBL] [Abstract][Full Text] [Related]
17. Magnetic field-assisted selective delivery of doxorubicin to cancer cells using magnetoliposomes as drug nanocarriers.
Szuplewska A; Rękorajska Joniec A; Pocztańska E; Krysiński P; Dybko A; Chudy M
Nanotechnology; 2019 Aug; 30(31):315101. PubMed ID: 30991371
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species (ROS) production in HepG2 cancer cell line through the application of localized alternating magnetic field.
Sola-Leyva A; Jabalera Y; Chico-Lozano MA; Carrasco-Jiménez MP; Iglesias GR; Jimenez-Lopez C
J Mater Chem B; 2020 Sep; 8(34):7667-7676. PubMed ID: 32705099
[TBL] [Abstract][Full Text] [Related]
19. Controlled Release of Doxorubicin from Magnetoliposomes Assisted by Low-Frequency Magnetic Field.
Maron E; Krysinski P; Chudy M
Chem Biodivers; 2023 Apr; 20(4):e202201079. PubMed ID: 36840686
[TBL] [Abstract][Full Text] [Related]
20. Combined Magnetoliposome Formation and Drug Loading in One Step for Efficient Alternating Current-Magnetic Field Remote-Controlled Drug Release.
Fortes Brollo ME; Domínguez-Bajo A; Tabero A; Domínguez-Arca V; Gisbert V; Prieto G; Johansson C; Garcia R; Villanueva A; Serrano MC; Morales MDP
ACS Appl Mater Interfaces; 2020 Jan; 12(4):4295-4307. PubMed ID: 31904927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
